Trial · NCT06718413
Myofascial Dysfunction in Post Stroke Shoulder Pain
NCT06718413, Phase 2, Recruiting, Johns Hopkins University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Myofascial Dysfunction in Post Stroke Shoulder Pain. Trials, record NCT06718413. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06718413
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Myofascial Dysfunction in Post Stroke Shoulder Pain
- NCT number
- NCT06718413
- Status
- Recruiting
- Phases
- Phase 2
- Enrollment
- 68 participants, estimated
- Lead sponsor
- Johns Hopkins University
- Conditions
- Stroke
- Interventions
- hyaluronidase plus saline, saline
- First posted
- 2024-12-05
- Last updated
- 2026-10-14
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | T1ρ relaxation times (ms) in the treatment group | Baseline, up to 7 weeks post first injection | Aim 1: T1ρ relaxation times in the treatment group. The primary endpoint will be change in T1ρ relaxation times on MRI in the shoulder girdle muscles of the paretic side between the baseline visit and 5-7 weeks post-first injection (i.e., post injection follow up at Visit 5/ end of Phase 1). |
| Secondary | Ultrasound shear strain | 7 weeks | Percent shear strain obtained via ultrasound in the two groups. Higher shear strain is better. |
| Secondary | Pain rating as assessed by algometer | 7 weeks | Pain rating on quantitative sensory testing of shoulder muscles. Lower pain rating is better. |
| Secondary | Pain free range of motion | 7 weeks | Range of motion for the most affected shoulder movement. Higher range of motion is better. |
| Secondary | Upper limb motion impairment as assessed by the Fugl-Meyer Scale | 7 weeks | Upper limb Fugl-Meyer scale; score range 0-66 with higher numbers reflecting less arm impairment |
| Secondary | Upper limb function as assessed by Wolf Motor Function Test (time) | 7 weeks | Participants are given a battery of functional tasks that are timed and scored on movement quality. Score range is 0-120, lower scores being better. |
| Secondary | Quality of life as assessed by the Stroke Impact Scale | 7 weeks | Scores range from 0-100, with higher score showing better quality of life and lower stroke impact. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| R33AT012279 | Quantifying and Treating Myofascial Dysfunction in Post Stroke Shoulder Pain | RAGHAVAN, PREETI | JOHNS HOPKINS UNIVERSITY | NATIONAL CENTER FOR COMPLEMENTARY & INTEGRATIVE HEALTH | 2024 |
Source NIH RePORTER
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06718413
GET https://conductscience.org/api/trials/v1/NCT06718413/registered